| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/23/2007 | WO2007094497A1 Ameliorating agent for metabolic syndrome |
| 08/23/2007 | WO2007094430A1 Cancer inhibitor, cancer inhibitor-containing product and process for producing cancer inhibitor |
| 08/23/2007 | WO2007094404A1 Process for production of optically active carboxylic acid compound |
| 08/23/2007 | WO2007094385A1 Adhesive patch for external use with improved cohesive force and sustained-release characteristics |
| 08/23/2007 | WO2007094384A1 External preparation for skin containing flavanone derivative |
| 08/23/2007 | WO2007094332A1 Disinfectant ointment |
| 08/23/2007 | WO2007094330A1 Peptide capable of activating bombesin-like peptide receptor and use thereof |
| 08/23/2007 | WO2007094312A1 Agent for promoting vitamin c transporter production |
| 08/23/2007 | WO2007094200A1 Skin-whitening cosmetic |
| 08/23/2007 | WO2007094166A1 Therapeutic agent for spinal cord injury |
| 08/23/2007 | WO2007094135A1 Oligonucleotide derivative and use thereof |
| 08/23/2007 | WO2007094071A1 Agent for improvement of hepatic function |
| 08/23/2007 | WO2007094026A1 Prophylactic and/or therapeutic treatment of proliferative and conformational diseases |
| 08/23/2007 | WO2007093963A1 Ethanol or 1,2-ethanediol cyclohexyl antibiotic derivatives |
| 08/23/2007 | WO2007093909A1 Novel pharmaceutical compositions for optimizing substitution treatments and extending the pharmacopoeia to global treatment of addictions |
| 08/23/2007 | WO2007093904A1 Benzoxazinone and benzoxazepinone oxazolidinones as antibacterial agents |
| 08/23/2007 | WO2007093901A1 3 -deazapurine derivatives as tlr7 modulators |
| 08/23/2007 | WO2007093880A2 Novel pyrone-indole derivatives and process for their preparation |
| 08/23/2007 | WO2007093873A1 Bis-pyrr0l0[2,l-c] [1, 4] benzodiazepine- anthraquinone conjugates as antitumour agents and a process for the preparation thereof |
| 08/23/2007 | WO2007093853A2 Compositions and methods for treatment and prevention of metabolic syndrome and its associated conditions with combinations of flavonoids, liminoids and tocotrienols |
| 08/23/2007 | WO2007093829A1 3-aminopyrazolines for treatment of neurodegenerative and psychiatric diseases |
| 08/23/2007 | WO2007093827A1 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
| 08/23/2007 | WO2007093824A1 Combination of alpha-2 receptor agonist (clonidin) and an anti-muscarinic agent (oxybutynin) for the treatment of sialorrhoea |
| 08/23/2007 | WO2007093769A1 Oligosaccharide biosynthesis inhibitors |
| 08/23/2007 | WO2007093747A2 Use of tesaglitizar for preparing a pharmaceutical composition for treating skin disorders |
| 08/23/2007 | WO2007093746A2 Use of muraglitazar for preparing a pharmaceutical composition for treating skin disorders |
| 08/23/2007 | WO2007093656A1 Use of derivatives of naphthalenesulphonic or quinolinesulphonic acid in the treatment of vasoproliferative ocular diseases |
| 08/23/2007 | WO2007093635A2 Proteasom or ups inhibitor for treating infections with influenza viruses |
| 08/23/2007 | WO2007093624A2 Pharmaceutical compositions for the treatment of attention deficit hyperactivity disorder comprising flibanserin |
| 08/23/2007 | WO2007093617A2 New stable hyperbaric composition comprising prilocaine hcl, use of said new composition for intrathecal anaesthesia, and method for manufacturing said composition |
| 08/23/2007 | WO2007093611A1 Fixed-dose association of phytate and zinc |
| 08/23/2007 | WO2007093610A1 Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture |
| 08/23/2007 | WO2007093608A1 Drug combinations for the treatment of respiratory tract diseases |
| 08/23/2007 | WO2007093604A1 Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 08/23/2007 | WO2007093603A1 1-phenethylpiperidine derivatives and their use as opioid receptor ligands |
| 08/23/2007 | WO2007093602A1 Enantiopure quinuclidinyloxy pyridazines and their use as nicotinic acetylcholine receptor ligands |
| 08/23/2007 | WO2007093601A1 3, 9-diazabicyclo(3.3.1)non-3-yl-aryl methanone derivatives as nicotinic acetylcholine receptor agonists |
| 08/23/2007 | WO2007093600A1 Novel diazabicycloalkane derivatives and their medical use |
| 08/23/2007 | WO2007093595A1 Substituted prolinamides, their preparation and their use as pharmaceuticals |
| 08/23/2007 | WO2007093587A1 Use of r-(-)-2,4-diamino-5-(2, 3-dichlorophenyl)-6-fluoromethyl pyrimidine for the treatment of psychotic disorders |
| 08/23/2007 | WO2007093578A1 Benzoisoindole derivatives and their use as ep4 receptor ligands |
| 08/23/2007 | WO2007093557A1 Sulfonamide derivatives for the treatment of bacterial infections |
| 08/23/2007 | WO2007093542A1 Pyridine-2-carboxamide derivatives |
| 08/23/2007 | WO2007093541A1 Heterocyclic antiviral compounds |
| 08/23/2007 | WO2007093540A1 Benzoyl-piperidine derivatives as 5ht2/d3 modulators |
| 08/23/2007 | WO2007093520A1 Hetero-bycyclic antiviral compounds |
| 08/23/2007 | WO2007093519A2 Ibandronate regimen for treating metastatic bone pain |
| 08/23/2007 | WO2007093515A1 Heterocyclic antiviral compounds |
| 08/23/2007 | WO2007093507A1 Heterobicyclic sulfonamide derivatives for the treatment of diabetes |
| 08/23/2007 | WO2007093425A2 Storage-stable oral dosage form of amoxicillin and clavulanic acid |
| 08/23/2007 | WO2007093409A2 Mcp-i binding nucleic acids |
| 08/23/2007 | WO2007093387A1 Novel nutraceutical and pharmaceutical compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders |
| 08/23/2007 | WO2007093375A1 Novel nutraceutical compositions and pharmaceutical compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders |
| 08/23/2007 | WO2007093366A1 Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
| 08/23/2007 | WO2007093364A1 Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
| 08/23/2007 | WO2007093363A1 Novel azacycly-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments |
| 08/23/2007 | WO2007093346A1 High dosage of mycophenolic acid (mpa) |
| 08/23/2007 | WO2007093328A1 Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders |
| 08/23/2007 | WO2007093264A1 Mandelic hydrazides |
| 08/23/2007 | WO2007093226A1 Oral ibandronate formulations |
| 08/23/2007 | WO2007093184A2 Treatment of mmp-mediated dermatological diseases with pemirolast |
| 08/23/2007 | WO2007093183A2 Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases |
| 08/23/2007 | WO2007093168A2 Rapid release irbesartan-containing pharmaceutical composition |
| 08/23/2007 | WO2007093090A1 The application of glycyrrhizic acid and its breakdown product glycyrrhetinic acid for the manufacture of a medicament for the treatment of inflammatory bowel disease |
| 08/23/2007 | WO2007093042A1 Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
| 08/23/2007 | WO2007093027A1 Delayed release pharmaceutical oral dosage form and method of making same |
| 08/23/2007 | WO2007093021A1 Package, or drug kit, or drug smooth administration presentation for the treatment of hypertension, angina and others kinds of cardiovascular diseases. |
| 08/23/2007 | WO2007079203A3 Treatment for cutaneous t cell lymphoma |
| 08/23/2007 | WO2007079202A3 Treatment for acute lymhoblastic leukemia |
| 08/23/2007 | WO2007079010A3 Carbonates of fenicol antibiotics |
| 08/23/2007 | WO2007077574A3 SULFOXIMINE DERIVATIVES AS p38 MAP KINASE INHIBITORS |
| 08/23/2007 | WO2007076085A3 Fused pyrimidones and thiopyrimidones, and uses thereof |
| 08/23/2007 | WO2007075884A3 Androgen receptor modulator compounds and methods |
| 08/23/2007 | WO2007075798A9 Methods and systems for the delivery of corticosteroids having an increased lung deposition |
| 08/23/2007 | WO2007075452A3 Lyophilized compositions of a triazolopyrimidine compound |
| 08/23/2007 | WO2007074170A3 Compositions and methods for the treatment and prevention of disease |
| 08/23/2007 | WO2007073518A9 Compounds and methods for thiol-containing compound efflux and cancer treatment |
| 08/23/2007 | WO2007071456B1 Fluorenes and carbazoles as ligands of the ep2 receptor |
| 08/23/2007 | WO2007071396A3 Pyrazinoylguanidine compounds useful in the treatment of inflammatory or allergic conditions |
| 08/23/2007 | WO2007070517A3 Fexofenadine suspension formulation |
| 08/23/2007 | WO2007068473A3 Organic compounds |
| 08/23/2007 | WO2007066068A3 Calcium ion channel receptor antagonist |
| 08/23/2007 | WO2007065664A3 Pyrazolo[1,5-a]pyridine-3-carboxylic acids as ephb and vegfr2 kinase inhibitors |
| 08/23/2007 | WO2007065619A3 Foam wafer containing a polyvinyl alcohol-polyethyleneglycol-graft copolymer |
| 08/23/2007 | WO2007065595A3 Xanthine derivatives, processes for preparing them and their uses |
| 08/23/2007 | WO2007064448A3 Cancer treatment using fts and 2-deoxyglucose |
| 08/23/2007 | WO2007062995A3 Glucan compositions |
| 08/23/2007 | WO2007061741A3 Modulators of the h3 receptor useful for the treatment of disorders related thereto |
| 08/23/2007 | WO2007059257A3 N4-phenyl-quinaz0line-4 -amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases |
| 08/23/2007 | WO2007058894A3 Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease |
| 08/23/2007 | WO2007056460A3 Treatment of length dependent neuropathy |
| 08/23/2007 | WO2007056275A3 Indole compounds having c4-amide substituents and use thereof as phospholipase-a2 inhibitors |
| 08/23/2007 | WO2007054566A3 Use of fenofibrate or a derivative thereof for preventing diabetic retinopathy |
| 08/23/2007 | WO2007053415A3 Agents for the treatment of cardiac arrhythmias |
| 08/23/2007 | WO2007052042A3 A hollow fibre-based biocompatible drug delivery device with one or more layers |
| 08/23/2007 | WO2007050866A3 Oligodendrocyte-myelin glycoprotein compositions and methods of use thereof |
| 08/23/2007 | WO2007039058A3 Use of opioid receptor antagonists |
| 08/23/2007 | WO2007035961A3 Anti-cancer therapies |
| 08/23/2007 | WO2007034312A3 Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome p450 3a4 (cyp3a4) |
| 08/23/2007 | WO2007030777A3 Amide and carbamate derivatives of alkyl substituted n-[4-(4-amino-1h-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamides and methods |